Full Press Release Details
dupixent dupilumab recommended for eu approval by the chmp to treat eosinophilic esophagitis eoe in children as young as 1 year old.
REGN
dupixent dupilumab recommended for eu approval by the chmp to treat eosinophilic esophagitis eoe in children as young as 1 year old
Key Takeaway: dupixent dupilumab recommended for eu approval by the chmp to treat eosinophilic esophagitis eoe in children as young as 1 year old